Ecor1 Capital, LLC: holdings and changes
Number 57 of the top 100 funds by copy return. Ecor1 Capital, LLC reported 34 US stocks worth $2.0B for the quarter ending 2026-09-30 and changed 9 new, 8 added, 3 trimmed and 6 sold since 2026-06-30.
Copy return, 4 quarters+44.6%
US 500, same time+14.5%
Size$2.0B
Stocks34
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| ZYME Zymeworks INC | 29.91% | $608M | 22,970,388 | |
| ANAB Anaptysbio INC | 19.47% | $396M | 7,880,094 | |
| CGON Cg Oncology INC | ADD +25% | 6.52% | $133M | 1,871,892 |
| ETON Eton Pharmaceuticals INC | ADD +14% | 6.25% | $127M | 2,470,920 |
| TRAX First Tracks Biotherapeutics | 5.53% | $112M | 3,174,519 | |
| AKTS Aktis Oncology INC | 4.62% | $94M | 4,824,469 | |
| CRSP Crispr Therapeutics Ag | 3.78% | $77M | 1,389,276 | |
| ANRO Alto Neuroscience INC | BUY | 2.80% | $57M | 2,232,000 |
| GALAPAGOS NV Galapagos Nv | 2.43% | $49M | 1,667,119 | |
| ERAS Erasca INC Com | ADD +794% | 2.13% | $43M | 2,950,000 |
| ORIC Oric Pharmaceuticals INC | TRIM -55% | 2.01% | $41M | 3,028,116 |
| NGNE Neurogene INC Com | 1.74% | $35M | 1,271,342 | |
| ATTO Attovia Therapeutics INC | BUY | 1.71% | $35M | 2,024,010 |
| FULC Fulcrum Therapeutics INC | ADD +4% | 1.24% | $25M | 6,803,785 |
| ADRX Adarx Pharmaceuticals INC | BUY | 1.13% | $23M | 1,150,000 |
| STOK Stoke Therapeutics INC | ADD +14% | 1.07% | $22M | 835,000 |
| ZBIO Zenas Biopharma INC | 1.05% | $21M | 789,500 | |
| ETRA Electra Therapeutics INC | BUY | 0.94% | $19M | 1,700,000 |
| ATRA Atara Biotherapeutics INC | 0.65% | $13M | 1,552,000 | |
| CAPR Capricor Therapeutics INC | BUY | 0.64% | $13M | 1,376,580 |
| XNCR Xencor INC | BUY | 0.61% | $12M | 500,000 |
| ODTX Odyssey Therapeutics, INC. | 0.61% | $12M | 555,555 | |
| AURA Aura Biosciences INC | 0.51% | $10M | 1,666,667 | |
| NRIX Nurix Therapeutics INC | ADD +39% | 0.44% | $9M | 375,000 |
| BRVE Braveheart Bio INC | BUY | 0.41% | $8M | 416,700 |
| PHVS Pharvaris N V | 0.37% | $8M | 235,000 | |
| EIKN Eikon Therapeutics INC | ADD +17% | 0.34% | $7M | 855,634 |
| ELOX Eloxx Pharmaceuticals INC | 0.30% | $6M | 400,000 | |
| AARD Aardvark Therapeutics INC | ADD +82% | 0.19% | $4M | 720,028 |
| BBOT Bridgebio Oncology Therapeutics Ord | TRIM -68% | 0.18% | $4M | 889,607 |
| TCGX Tcgx Acquisition Corp | BUY | 0.15% | $3M | 250,000 |
| ZURA Zura Bio LTD | TRIM -42% | 0.14% | $3M | 679,715 |
| HLXC Helix Acquisition Corp III | 0.10% | $2M | 200,000 | |
| CTNM Contineum Therapeutics INC | BUY | 0.04% | $900k | 64,303 |
| LEGN Legend Biotech Corp | SELL | 0% | was $23M | 0 |
| MBX Mbx Biosciences INC | SELL | 0% | was $21M | 0 |
| RLAY Relay Therapeutics INC | SELL | 0% | was $13M | 0 |
| PHAT Phathom Pharmaceuticals INC | SELL | 0% | was $7M | 0 |
| MREO Mereo Biopharma Group PLC | SELL | 0% | was $300k | 0 |
| SRZN Surrozen INC | SELL | 0% | was $0k | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2023-09-30 → 2023-12-31 | +18.0% | +11.2% |
| 2023-12-31 → 2024-03-31 | -2.9% | +10.0% |
| 2024-03-31 → 2024-06-30 | -18.7% | +4.0% |
| 2024-06-30 → 2024-09-30 | -0.9% | +5.4% |
| 2024-09-30 → 2024-12-31 | -11.8% | +2.1% |
| 2024-12-31 → 2025-03-31 | -26.1% | -4.6% |
| 2025-03-31 → 2025-06-30 | -2.1% | +10.5% |
| 2025-06-30 → 2025-09-30 | +41.2% | +7.8% |
| 2025-09-30 → 2025-12-31 | +24.7% | +2.4% |
| 2025-12-31 → 2026-03-31 | +5.6% | -4.6% |
| 2026-03-31 → 2026-06-30 | +15.7% | +14.8% |
| 2026-06-30 → 2026-09-30 | -5.1% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP